Neohormone systems as exciting targets for drug development

被引:21
作者
Ivell, R [1 ]
Bathgate, R
机构
[1] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia
[2] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia
关键词
D O I
10.1016/j.tem.2006.03.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:123 / 123
页数:1
相关论文
共 6 条
[1]   Relaxin: new peptides, receptors and novel actions [J].
Bathgate, RAD ;
Samuel, CS ;
Burazin, TCD ;
Gundlach, AL ;
Tregear, GW .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (05) :207-213
[2]   Relaxin peptides are new global players [J].
Ivell, R ;
Einspanier, A .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (08) :343-348
[3]   Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model [J].
Perna, AM ;
Masini, E ;
Nistri, S ;
Briganti, V ;
Chiappini, L ;
Stefano, P ;
Bigazzi, M ;
Pieroni, C ;
Sacchi, TB ;
Bani, D .
FASEB JOURNAL, 2005, 19 (09) :1525-+
[4]   Relaxin: Antifibrotic Properties and Effects in Models of Disease [J].
Samuel, Chrishan S. .
CLINICAL MEDICINE & RESEARCH, 2005, 3 (04) :241-249
[5]   Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites [J].
Unemori, EN ;
Lewis, M ;
Constant, J ;
Arnold, G ;
Grove, BH ;
Normand, J ;
Deshpande, U ;
Salles, A ;
Pickford, LB ;
Erikson, ME ;
Hunt, TK ;
Huang, XF .
WOUND REPAIR AND REGENERATION, 2000, 8 (05) :361-370
[6]   Evolution of the relaxin-like peptide family [J].
Wilkinson, TN ;
Speed, TP ;
Tregear, GW ;
Bathgate, RA .
BMC EVOLUTIONARY BIOLOGY, 2005, 5 (1)